Great Point Partners’s Traws Pharma TRAW Stock Holding History

Great Point Partners’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10	Closed	-$1.82M	–	40
2014 Q4	$1.82M	Buy	10 +4	+67%	+$978K	0.88%	21
2014 Q3	$1.49M	Buy	6 +4	+200%	+$1.14M	0.64%	30
2014 Q2	$594K	Buy	+2	New	+$590K	0.26%	38

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Great Point Partners's TRAW Position: Q1 2015 in Review

Great Point Partners sold out of Traws Pharma (TRAW) in Q1 2015, closing a stake of 10 shares — an estimated $1.82M sold.

Great Point Partners first reported a position in TRAW in Q2 2014 and held it in 3 quarters. The position peaked at $1.82M in Q4 2014. 9 funds tracked by Wall St. Rank hold TRAW as of Q1 2015.

Great Point Partners reported no remaining Traws Pharma position as of Q1 2015 after selling out during the quarter.
Great Point Partners sold 10 Traws Pharma shares in Q1 2015, an estimated $1.82M.
Great Point Partners first reported a position in Traws Pharma in Q2 2014 and held it in 3 quarters.
Great Point Partners's Traws Pharma position peaked at $1.82M in Q4 2014.
9 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2015.

Based on Great Point Partners's 13F filing for Q1 2015, filed 15 May 2015.